2024
Long-acting HIV Treatments: Study Design, Logistics, and Access
Murdock NA, Alajaji NE, Schaefer R, Boone CA, Campo RE, Dore GJ, Gandhi M, Gorospe JR, Gulick RM, Hodder SL, Liu J, Rhee MS, Rooney JF, Vannappagari V, Wilkin T, Miller V. Long-acting HIV Treatments: Study Design, Logistics, and Access. Open Forum Infectious Diseases 2024;11(7):ofae337.
2023
Facilitating next-generation pre-exposure prophylaxis (PrEP) clinical trials using HIV recent infection assays: a consensus statement from the Forum HIV Prevention Trial Design Project
Parkin N, Gao F, Grebe E, Cutrell A, Das M, Donnell D, Duerr A, Glidden DV, Hughes JP, Murray J, Robertson MN, Zinserling J, Lau J, Miller V. Clin Pharmacol Ther. Clin Pharmacol Ther. 2023;114:29-40.
2022
A systematic review of limiting antigen avidity enzyme immunoassay for detection of recent HIV-1 infection to expand supported applications
Lau J, Murdock N, Murray J, Justman J, Parkin N, Miller V. J Virus Erad. 2022 Sep 7;8(3):100085
2021
Association between rectal gonorrhoea and HIV incidence in men who have sex with men: a meta-analysis
Donnell D, Zewdie K, Ratna N, Miller V, Saunders J, Gill O, Delpech V, Mohammed H. Sexually Transmitted Infections 2022;98:492-496
2014
HIV and HCV Infection in the United States: Whom and How to Test
Panneer N, Lontok E, Branson BM, Teo CG, Dan C, Parker M, Stekler JD, DeMaria A Jr, Miller V. Clin Infect Dis. 2014 May 27. pii: ciu396
2013
The Untold Story of How High-Quality and Low-Cost Drugs Were Incorporated Into PEPFAR.
Quinones-Rivera, A. Annals Of The Forum For Collaborative HIV Research, 15(1). (2013).
2012
Novel Clinical Trial Designs for the Development of New Antiretroviral Agents
Mani N, Murray J, Gulick RM, Josephson F, Miller V, Miele P, Strobos J, Struble KA. Novel clinical trial designs for the development of new antiretroviral agents. AIDS. 26(8):899-907, May 15, 2012.
Adverse Outcome Analyses of Observational Data: Assessing Cardiovascular Risk in HIV Disease
Triant V, Josephson F, Rochester CG, Althoff KN, Marcus K, Munk R, Cooper C, D'Agostino RB, Costagliola D, Sabin CA, Williams PL, Hughes S, Post WS, Chandra-Strobos N, Guaraldi G, Young SS, Obenchain R, Bedimo R, Miller V, Strobos J. Adverse outcome analyses of observational data: assessing cardiovascular risk in HIV disease. Clin Infect Dis. 2012 Feb 1;54(3):408-13
2011
Safety Considerations in the Prevention of Transmission of HIV by Pre-Exposure Prophylaxis (or "PrEP")
Jur Strobos, Benjamin C Hauschild, Veronica Miller
Ann Forum Collab HIV Res: Vol 13, No 5. Nov. 28, 201.
Municipal Scale-up of HIV Testing in the United States: Current Status, Challenges and Opportunities from a Multi-Stakeholder Perspective
Benjamin C Hauschild, Veronica Miller, Jur Strobos
Ann Forum Collab HIV Res: Vol 13, No 4
Nov. 7, 2011
Recommendations from a Research Consultation to Inform the Next Generation of HIV Prevention Messaging for Men Who Have Sex with Men (MSM)
Jennifer Uhrig, Megan A Lewis, George Ayala,, Jo Ellen Stryker
Ann Forum Collab HIV Res
Oct. 3, 2011
Global Pharmacovigilance for Antiretroviral Drugs: Overcoming Contrasting Priorities
Bakare N, Edwards IR, Stergachis A, Pal S, Holmes CB, Lindquist M, et al. Global pharmacovigilance for antiretroviral drugs: overcoming contrasting properties. PLoS Med 2011 Jul;8(7):e1001054.Epub 2011 Jul 5.
Recognizing Leadership, Courage and Hands-On Engagement: Relearning Lessons 30 Years Later
Veronica Miller
Ann Forum Collab HIV Res
Mar. 29, 2011
Presentation of the C. Everett Koop HIV/AIDS Health Leadership Award to VADM C. Everett Koop, MD, SCD, 13th U.S. Surgeon General
Anthony S. Fauci
Ann Forum Collab HIV Res
Mar. 29, 2011
The Early Days of AIDS, As I Remember Them
C. Everett Koop
Ann Forum Collab HIV Res
Mar. 29, 2011
Sequence and Phenotypic Analysis for Resistance Monitoring in Hepatitis C Virus Drug Development: Recommendations from the HCV DRAG
Ann D. Kwong, Isabel Najera, Jill Bechtel, Steven Bowden, Joseph Fitzgibbon, Patrick Harrington, Dale Kempf, Tara L. Kieffer, Diana Koletzki, George Kukolj, Sharlene Lim, Tami Pilot-Matias, Kai Lin, Nina Mani, Hongmei Mo, Jules O'Rear, Michael Otto, Neil Parkin, Jean-Michel Pawlotsky, Christos Petropoulos, Gaston Picchio, Robert Ralston, Jacqueline D. Reeves, Robert T. Schooley, Scott Seiwert, David Standring, Lieven Stuyver, James Sullivan, Veronica Miller, Forum for Collaborative HIV Research, HCV Drug Development Advisory Group (HCV DrAG), Sequence Analysis Working Group (SAWG), Phenotype Analysis Working Group (PAWG). Sequence and phenotypic analysis for resistance monitoring in hepatitis c virus drug development: recommendations from the HCV DrAG. Gastroenterology. 2011 Mar 12;140(3):755-60
HIV Clinic Capacity and Medical Workforce Challenges: Results of a Survey of Ryan White Part C-funded Programs
Benjamin C. Hauschild, Andrea Weddle, Jenny K. Tegelvik, Christine Lubinski, Veronica Miller, Michael S. Saag
Ann Forum Collab HIV Res
Jan. 21, 2011
2010
2010 National Summit on HIV Diagnosis, Prevention and Access to Care. November 17, 2010
2009
The Forum for Collaborative HIV Research: A Model for an Integrated and Inclusive Approach to Clinical Research and Drug Development
Miller V. The forum for collaborative HIV research: a model for an integrated and inclusive approach to clinical research and drug development. Clin Pharmacol Ther. 2009 Sep 1;86(3):332-5. Sep. 1, 2009
Evaluation of Impact of Adult Male Circumcision Programs on HIV Incidence and Prevalence: Current Research, Gaps in Knowledge and Recommendations for Additional Research
Sarah Kim, Shrimant Mishra, Veronica Miller
Ann Forum Collab HIV Res
Apr. 23, 2009
Metrics and Evaluation Measures for Monitoring the Implementation of Routine HIV Testing in the U.S.
Benjamin Hauschild, Linda Onaga
Ann Forum Collab HIV Res
Apr. 23, 2009
2008
HIV Clinical Trial Design for Antiretroviral Development: Moving Forward
Chan-Tack KM, Struble KA, Morgensztejn N, Murray JS, Cheng B, Weller I, Miller V. HIV clinical trial design for antiretroviral development: moving forward. AIDS. 2008 Nov 30;22(18):2419-27.
Opt-Out Testing for Human Immunodeficiency Virus in the United States: Progress and Challenges
Bartlett JG, Branson BM, Fenton K, Hauschild BC, Miller V, Mayer KH. Opt-out testing for human immunodeficiency virus in the united states: progress and challenges. JAMA. 2008 Aug 27;300(8):945-951.
Initiatives for Developing and Comparing Genotype Interpretation Systems Step 1: External Validation of Existing Rules-Based Algorithm for Abacavir and ddI Evaluated on Virological Response
Assoumou L, Brun-V zinet F, Cozzi-Lepri A, Kuritzkes D, Phillips A, Zolopa A, DeGruttola V, Miller V, Costagliola D. Initiatives for developing and comparing genotype interpretation systems step 1: external validation of existing rules-based algorithm for abacavir and ddI evaluated on virological response. Journal of Infectious Diseases. 2008 Aug 15;198(4):470-80.
Research Needs and Challenges in the Development of HIV Diagnostic and Treatment Monitoring Tests for Use in Resource-Limited Settings
Cheng B, Landay A, Miller V. Research needs and challenges in the development of HIV diagnostic and treatment monitoring tests for use in resource-limited settings. Curr Opin HIV AIDS;2008 Jul 1;3(4):495-503.
Meeting the Demand for Male Circumcision
Nyasha Bakare, Veronica Miller
Ann Forum Collab HIV Res
Jun. 17, 2008
ARV Drugs, Adverse Events, Case Definition, Grading, Laboratory Diagnosis and Treatment Monitoring
Veronica Miller
Ann Forum Collab HIV Res
Jun. 17, 2008
2007
HIV-TB Co-Infection: Meeting the Challenge
Nyasha Bakare, Veronica Miller
Ann Forum Collab HIV Res
Nov. 2, 2007
Rethinking the Approach to Expanded Access Programs
Eric Zechman, Ben Cheng, Veronica Miller
Ann Forum Collab HIV Res
Jun. 14, 2007
Collaborative Approaches to HIV Drug Development: Planning for Long-Term Monitoring of Safety in CCR5 Antagonist Development
John Fry, Johanna Bogulavsky Grossman, Veronica Miller
Ann Forum Collab HIV Res
Apr. 24, 2007
A New Era for HIV Prevention?
Chris Collins, Meagan Lyon, Veronica Miller
Ann Forum Collab HIV Res
Feb. 1, 2007
HIV and TB in the Context of Universal Access: What is Working and What is not? Meeting Report
The World Health Organization
hivforum.org
2007
2006
Buprenorphine and HIV Primary Care: New Opportunities for Integrated Treatment
Khalsa J, Vocci F, Altice F, Fiellin D, Miller V. Buprenorphine and HIV primary care: new opportunities for integrated treatment. Clin Infect Dis. 2006 Dec 15;43(4):169-72.
Pediatric HIV Diagnosis & Laboratory Monitoring
Veronica Miller
Ann Forum Collab HIV Res
Nov. 1, 2006
Racial Ethnic Minority Issues in HIV/AIDS
Craig Hunter, Veronica Miller
Ann Forum Collab HIV Res
Nov. 1, 2006
HIV-1 Viral Load Assays for Resource-Limited Settings
Fiscus SA, Cheng B, Crowe SM, Demeter L, Jennings C, et al. (2006) HIV-1 viral load assays for resource-limited settings. PLoS Med 3(10): e417. doi:10.1371/journal.pmed.0030417
International Public Health Dialogue on HIV Testing and Counselling Report
Public Health Agency of Canada
hivforum.org
Aug. 17, 2006
2005
Meeting Summary and Report: Developing and HIV Health Services Research Agenda
Jeffrey Levi, Veronica Miller
Ann Forum Collab HIV Res
Jun. 1, 2005
Antiretroviral Therapies for Treatment Experienced Patients: Current Status and Research Challenges
Struble KA, Murray JS, Cheng B, Gegeny T, Miller V, Gulick RM. Antiretroviral therapies for treatment experienced patients: current status and research challenges. AIDS. 2005 May 20;19(8):747-56.
Regulatory Considerations for the Treatment of Lipodystrophy
Sally Snyder, Ben Cheng, Veronica Miller
Ann Forum Collab HIV Res
May 1, 2005
Buprenorphine and Primary HIV Care
Jeanine Warden, Craig Hunter, Veronica Miller
Ann Forum Collab HIV Res
Mar. 2005
2004
Roundtable Report: Importance of Antiretroviral Drug Levels in Sanctuary Sites and Viral Reservoirs
Reddy YS, Kashuba A, Gerber J, Miller V. Roundtable report: importance of antiretroviral drug levels in sanctuary sites and viral reservoirs. AIDS Research and Human Retroviruses. 2004 Jul 5;19(3):167-76.
2003
Quality of HIV Care - Closing the Gap: A Report on the Findings from the Quality of HIV Care Project
Veronica Miller
Ann Forum Collab HIV Res
Dec. 4, 2003
Monitoring of long-term toxicities of HIV treatments: an international perspective
Greg Bisson, Robert Gross, Veronica Miller, Ian Weller, Alexander Walker, on behalf of the writing group
AIDS
Nov. 21, 2003
Protein Binding in Antiretroviral Therapies
Marta Boffito, David J. Back, Terrence F. Blaschke, Malcolm Rowland, Richard J. Bertz, John G. Gerber, and Veronica Miller on behalf of the roundtable participants
AIDS Research and Human Retroviruses
Nov. 9, 2003
QA/QC of CD4 and Viral Load Assays in the Resource-Limited Setting
Kevin Moody, Veronica Miller
Ann Forum Collab HIV Res
Oct. 30, 2003
Cardiovascular Risk in HIV Infection and Treatment
Mark Mascolini, Veronica Miller
Ann Forum Collab HIV Res
May 22, 2003
Forum for Collaborative HIV Research Summary of Executive Committee Retreat
Veronica Miller
Ann Forum Collab HIV Res
Mar. 19, 2003
STI Roundtable Discussion: Moving the Agenda Forward
Richard Jefferys, Veronica Miller
Ann Forum Collab HIV Res
Feb. 8, 2003
2002
What Defines HIV Lipodystrophy?
Mark Mascolini, Veronica Miller
Ann Forum Collab HIV Res
Sep. 23, 2002
Report of the Workshop: Sex and Gender Issues in HIV Disease
Veronica Miller
Ann Forum Collab HIV Res
Sep. 4, 2002
Cheaper HIV Drugs for Poor Nations Bring a New Challenge: Monitoring Treatment
Joan Stephenson
JAMA
Jul. 10, 2002
Transfer of HIV Diagnostic and Monitoring Technologies into Resource-Poor Settings
Le Transfert des Technologies pour le Diagnostic et le Monitoring de l'Infection VIH dans les Pays en Développement (French Version)
Mark Mascolini, Veronica Miller
Ann Forum Collab HIV Res
May 2002
Report from the 3rd International STI Workshop
Richard Jefferys, Veronica Miller
Ann Forum Collab HIV Res
Apr. 22, 2002
2001
Linkage and Integration of HIV Testing, Prevention, and Care
John Palen, Veronica Miller
Ann Forum Collab HIV Res
Oct. 2001
Linking HIV Testing, Prevention and Care
Helen Schietinger
Ann Forum Collab HIV Res
Sep. 21, 2001
Examining the Risk and Benefits of Directly Observed Therapy for Treatment of HIV Disease
Karen Eddelman
Ann Forum Collab HIV Res
Apr. 17, 2001
Immunologic Markers to Evaluate Immune-Based Therapies in HIV Disease Meeting Reporting
Mark Mascolini
Ann Forum Collab HIV Res
Feb. 6, 2001
Structured Treatment Interruptions Workshop Summary
Veronica Miller
Ann Forum Collab HIV Res
Jan. 31, 2001
Report of the DHHS Working Group on Dissemination of HIV Treatment Information
Veronica Miller
Ann Forum Collab HIV Res
2001
2000
Immune-Based Therapies: A Review of Clinical Endpoints Used in Trials of Selected Immunologic Agents
Karen Eddleman, Veronica Miller
Ann Forum Collab HIV Res
Dec. 1, 2000
Immune-Based Therapies and HIV Disease
Alan Landay, June Bray, Veronica Miller
Ann Forum Collab HIV Res
Dec. 7, 2000
Bone Metabolism and HIV Disease Meeting Report
Lawrence Raisz, Jane Aubin, Veronica Miller
Ann Forum Collab HIV Res
Aug. 29, 2000
Mitochondrial Toxicity and HIV Disease Meeting Report
Kees Brinkman, William Copeland, Veronica Miller
Ann Forum Collab HIV Res
Jun. 5, 2000
Meeting on Drug Interaction Research in HIV Disease
David Barr, Veronica Miller
Ann Forum Collab HIV Res
Apr. 1, 2000
1999
Adherence to HIV Therapy: Building a Bridge to Success
DHHS Health Resources and Services Administration (HRSA) and The Forum for Collaborative HIV Research in collaboration with NIH Office of AIDS Research
hivforum.org
Nov. 15, 1999
Adherence to Highly Active Antiretroviral Therapy (HAART) Among Individuals
David Barr, Robert D. Webster
hivforum.org
Nov. 15, 1999
The Potential of Patient Outcomes Research
Helen Schietinger
Ann Forum Collab HIV Res
Sep. 1, 1999
Simplifying Antiretroviral Treatment Regimens-A Summary of Current Research
Dave Gilden
hivforum.org
Jun. 1, 1999
Failure of Initial Antiretroviral Treatment Regimens
David Gilden
Ann Forum Collab HIV Res
Jan. 1999
The Challenges of Clinical Trial Design in Assessing the Effects of Anti-HIV Therapy in Heavily Pre-Treated Patients
David Barr
Ann Forum Collab HIV Res
1999
1998
David Barr Speech at 4th Conference on Drug Therapy in Glasgow, Scotland
David Barr
hivforum.org
Nov. 1, 1998
HIV Treatment Failure: A Review of Clinical Research
Mark Harrington, Julia Hidalgo
Ann Forum Collab HIV Res
Jun. 1, 1998
Metabolic Consequences of HIV Disease and Treatment
Robert Munk
Ann Forum Collab HIV Res
1998
Dissemination and Evaluation of Clinical Practice Guidelines for HIV
Tina Sogocio, David Barr
Ann Forum Collab HIV Res
1998
FCHR Project on Metabolic Abnormalities in HIV Disease and Treatment: The Need for an Interim Case Definition and a Study to Examine Prevalence
Susan Brobst
Ann Forum Collab HIV Res
1998
1997
Adherence to New HIV Therapies: A Research Conference
(Author)
hivforum.org
Nov. 21, 1997
1996
The Keystone National Policy Dialogue on Establishment of Studies to Optimize Medical Management of HIV Infection
Keystone National Policy Dialogue Keystone Center
Ann Forum Collab HIV Res
Aug. 2, 1996
